13D/13G Filings - Candel Therapeutics Inc. (CADL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-17
12:30 pm
Purchase
2024-12-1313GCandel Therapeutics, Inc.
CADL
CVI Investments, Inc.2,350,000
5.600%
2,350,000increase
(New Position)
Filing
History
2023-02-09
09:59 am
Sale
2023-02-0913GCandel Therapeutics, Inc.
CADL
FMR LLC737,596
2.552%
-1,525,246decrease
(-67.40%)
Filing
History
2022-02-14
4:40 pm
Purchase
2021-12-3113GCandel Therapeutics, Inc.
CADL
Northpond Ventures LP1,935,215
6.700%
1,935,215increase
(New Position)
Filing
History
2022-02-14
4:38 pm
Purchase
2021-07-2913DCandel Therapeutics, Inc.
CADL
Manning Paul B4,073,316
13.600%
4,073,316increase
(New Position)
Filing
History
2022-02-09
09:11 am
Purchase
2022-02-0813GCandel Therapeutics, Inc.
CADL
FMR LLC2,262,842
7.887%
2,262,842increase
(New Position)
Filing
History